These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
163 related items for PubMed ID: 23949314
1. Arsenic trioxide suppressed mantle cell lymphoma by downregulation of cyclin D1. Lo RK, Kwong YL. Ann Hematol; 2014 Feb; 93(2):255-65. PubMed ID: 23949314 [Abstract] [Full Text] [Related]
2. Luteolin induces G1 arrest in human nasopharyngeal carcinoma cells via the Akt-GSK-3β-Cyclin D1 pathway. Ong CS, Zhou J, Ong CN, Shen HM. Cancer Lett; 2010 Dec 08; 298(2):167-75. PubMed ID: 20655656 [Abstract] [Full Text] [Related]
3. The antitumor effects of arsenic trioxide in mantle cell lymphoma via targeting Wnt/β‑catenin pathway and DNA methyltransferase-1. Li XY, Li Y, Zhang L, Liu X, Feng L, Wang X. Oncol Rep; 2017 Nov 08; 38(5):3114-3120. PubMed ID: 28901456 [Abstract] [Full Text] [Related]
4. Induction of apoptosis and down regulation of cell cycle proteins in mantle cell lymphoma by flavopiridol treatment. Venkataraman G, Maududi T, Ozpuyan F, Bahar HI, Izban KF, Qin JZ, Alkan S. Leuk Res; 2006 Nov 08; 30(11):1377-84. PubMed ID: 16624404 [Abstract] [Full Text] [Related]
5. Arsenic trioxide-mediated growth inhibition in MC/CAR myeloma cells via cell cycle arrest in association with induction of cyclin-dependent kinase inhibitor, p21, and apoptosis. Park WH, Seol JG, Kim ES, Hyun JM, Jung CW, Lee CC, Kim BK, Lee YY. Cancer Res; 2000 Jun 01; 60(11):3065-71. PubMed ID: 10850458 [Abstract] [Full Text] [Related]
6. Cyclin D1 degradation is sufficient to induce G1 cell cycle arrest despite constitutive expression of cyclin E2 in ovarian cancer cells. Masamha CP, Benbrook DM. Cancer Res; 2009 Aug 15; 69(16):6565-72. PubMed ID: 19638577 [Abstract] [Full Text] [Related]
7. Mechanism of the antitumoral activity of deferasirox, an iron chelation agent, on mantle cell lymphoma. Vazana-Barad L, Granot G, Mor-Tzuntz R, Levi I, Dreyling M, Nathan I, Shpilberg O. Leuk Lymphoma; 2013 Apr 15; 54(4):851-9. PubMed ID: 23020673 [Abstract] [Full Text] [Related]
8. Arsenic trioxide-mediated growth inhibition in gallbladder carcinoma cells via down-regulation of Cyclin D1 transcription mediated by Sp1 transcription factor. Ai Z, Lu W, Ton S, Liu H, Sou T, Shen Z, Qin X. Biochem Biophys Res Commun; 2007 Aug 31; 360(3):684-9. PubMed ID: 17617380 [Abstract] [Full Text] [Related]
9. Retinoic acid inhibits the proliferative response induced by CD40 activation and interleukin-4 in mantle cell lymphoma. Guidoboni M, Zancai P, Cariati R, Rizzo S, Dal Col J, Pavan A, Gloghini A, Spina M, Cuneo A, Pomponi F, Bononi A, Doglioni C, Maestro R, Carbone A, Boiocchi M, Dolcetti R. Cancer Res; 2005 Jan 15; 65(2):587-95. PubMed ID: 15695403 [Abstract] [Full Text] [Related]
10. Synergistic anticancer effects of arsenic trioxide with bortezomib in mantle cell lymphoma. Jung HJ, Chen Z, McCarty N. Am J Hematol; 2012 Dec 15; 87(12):1057-64. PubMed ID: 22965904 [Abstract] [Full Text] [Related]
11. GSK3β-dependent cyclin D1 and cyclin E1 degradation is indispensable for NVP-BEZ235 induced G0/G1 arrest in neuroblastoma cells. Liu SL, Liu Z, Zhang LD, Zhu HQ, Guo JH, Zhao M, Wu YL, Liu F, Gao FH. Cell Cycle; 2017 Dec 15; 16(24):2386-2395. PubMed ID: 28980866 [Abstract] [Full Text] [Related]
12. Antitumoral activity of lenalidomide in in vitro and in vivo models of mantle cell lymphoma involves the destabilization of cyclin D1/p27KIP1 complexes. Moros A, Bustany S, Cahu J, Saborit-Villarroya I, Martínez A, Colomer D, Sola B, Roué G. Clin Cancer Res; 2014 Jan 15; 20(2):393-403. PubMed ID: 24178620 [Abstract] [Full Text] [Related]
13. Resibufogenin Induces G1-Phase Arrest through the Proteasomal Degradation of Cyclin D1 in Human Malignant Tumor Cells. Ichikawa M, Sowa Y, Iizumi Y, Aono Y, Sakai T. PLoS One; 2015 Jan 15; 10(6):e0129851. PubMed ID: 26121043 [Abstract] [Full Text] [Related]
14. Temsirolimus downregulates p21 without altering cyclin D1 expression and induces autophagy and synergizes with vorinostat in mantle cell lymphoma. Yazbeck VY, Buglio D, Georgakis GV, Li Y, Iwado E, Romaguera JE, Kondo S, Younes A. Exp Hematol; 2008 Apr 15; 36(4):443-50. PubMed ID: 18343280 [Abstract] [Full Text] [Related]
15. P276-00, a cyclin-dependent kinase inhibitor, modulates cell cycle and induces apoptosis in vitro and in vivo in mantle cell lymphoma cell lines. Shirsath NP, Manohar SM, Joshi KS. Mol Cancer; 2012 Oct 18; 11():77. PubMed ID: 23075291 [Abstract] [Full Text] [Related]
16. Arsenic trioxide rewires mantle cell lymphoma response to bortezomib. Zhao LL, Liu YF, Peng LJ, Fei AM, Cui W, Miao SC, Hermine O, Gressin R, Khochbin S, Chen SJ, Wang J, Mi JQ. Cancer Med; 2015 Nov 18; 4(11):1754-66. PubMed ID: 26310857 [Abstract] [Full Text] [Related]
17. Transcription and translation are primary targets of Pim kinase inhibitor SGI-1776 in mantle cell lymphoma. Yang Q, Chen LS, Neelapu SS, Miranda RN, Medeiros LJ, Gandhi V. Blood; 2012 Oct 25; 120(17):3491-500. PubMed ID: 22955922 [Abstract] [Full Text] [Related]
18. Arsenic trioxide inhibits cell growth in SH-SY5Y and SK-N-AS neuroblastoma cell lines by a different mechanism. Woo SY, Lee MY, Jung YJ, Yoo ES, Seoh JY, Shin HY, Ahn HS, Ryu KH. Pediatr Hematol Oncol; 2006 Oct 25; 23(3):231-43. PubMed ID: 16517539 [Abstract] [Full Text] [Related]
19. Deferasirox induces cyclin D1 degradation and apoptosis in mantle cell lymphoma in a reactive oxygen species- and GSK3β-dependent mechanism. Samara A, Shapira S, Lubin I, Shpilberg O, Avigad S, Granot G, Raanani P. Br J Haematol; 2021 Feb 25; 192(4):747-760. PubMed ID: 33521925 [Abstract] [Full Text] [Related]
20. GSK-3beta regulates cyclin D1 expression: a new target for chemotherapy. Takahashi-Yanaga F, Sasaguri T. Cell Signal; 2008 Apr 25; 20(4):581-9. PubMed ID: 18023328 [Abstract] [Full Text] [Related] Page: [Next] [New Search]